A white paper for a decentralized blockchain platform to crowdfund life sciences research & tokenize biotech intellectual property rights. v1.8 is an archived white paper, originally published in mid-2017.

ABSTRACT

AQUA.Foundation is reimagining intellectual property (IP) rights on the blockchain frontier, starting with life science R&D. We all understand how delays in bringing new drugs and therapies to market are costing patients’ lives, in addition to tremendous amounts of wasted research dollars. AQUA unlocks collaboration, and generates new intellectual wealth by defining, protecting and providing liquidity to IP rights. 

AQUA is a blockchain-powered life science R&D funding platform that accelerates breakthrough drugs and therapies to market by enabling companies to monetize their IP rights. AQUA will save millions of patients from suffering and death and billions of dollars in R&D time by providing liquidity to companies in exchange for fractional IP rights early in their lifecycle. 

AQUA transforms illiquid but valuable IP rights into liquid, divisible, immutable, and fractional IP rights through tradable AQUA Tokens. AQUA shortens R&D lifecycles and aligns their timelines with those of investor expectations. In this way, AQUA will unleash a Cambrian explosion in life science R&D.

ABOUT AQUA

Creators of the AQUA Platform have the perfect balance of Life Sciences, Entrepreneurship, Deep Technical knowledge and Crypto experience. Together, Dr. Chandra Duggirala, M.D., George Burke, and Manoj Duggirala previously founded and ran a hyper-personalized digital nutritionist/nutrition delivery startup that integrated subscribers’ digital health analytics (TryFuel.com) with DNA and other biomarkers to deliver hyper-personalized meals nationwide. They took the concept from idea through successful product development, fundraising, and market execution, building a 7-figure annual run rate (ARR) company in less than 1 year. 

The team envisioned the AQUA project during 2017. Together, they have developed several blockchain initiatives and proofs-of-concept that reenvision Biotech R&D, Intellectual Property rights, Insurance, Cryptoeconomics, Crowdfunding, and Digital Asset Trading/Exchange.